As of the latest Form 4 filed Jun 18, 2026.
What EMCOR Group Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 32 most recent filings for EME.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | 2026-06-17 | Lowe Carol P Director | SSale | −950.00 | $844.50 | $802K | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Walker-Lee Robin A Director | AAward | +230.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Schwarzwaelder Steven Director | AAward | +230.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | ROCHE PATRICK J Director | AAward | +304.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | MCEVOY M KEVIN Director | AAward | +230.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Lowe Carol P Director | AAward | +304.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Johnson Ronald L Director | AAward | +230.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | DAHL AMY E Director | AAward | +230.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Altmeyer John W Director | AAward | +304.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Reid William P Director | SSale | −2.00K | $925.78 | $1.85M | No | Form 4 ↗ |
| 2026-05-05 | 2026-05-01 | Altmeyer John W Director | SSale | −2.50K | $895.00 | $2.24M | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Lind Robert Peter VP and Controller | SSale | −675.00 | $894.27 | $604K | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Nalbandian Jason R SVP, CFO, Chief Acct. Officer | SSale | −800.00 | $856.43 | $685K | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Guzzi Anthony Chairman, President and CEO | GGift | −3.00K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Schwarzwaelder Steven Director | SSale | −5.60K | $895.19 | $5.01M | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Reid William P Director | AAward | +1.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Altmeyer John W Director | AAward | +2.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Nalbandian Jason R SVP, Chief Acct Officer & CFO | AAward | +4.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Mauricio Maxine Lum CAO, EVP & General Counsel | AAward | +4.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Guzzi Anthony Chairman, President and CEO | AAward | +13.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Mauricio Maxine Lum CAO, EVP & General Counsel | GGift | −1.38K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Guzzi Anthony Chairman, President and CEO | SSale | −36.0K | $729.48 | $26.3M | Yes (planned) | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Lind Robert Peter VP and Controller | FTax | −233.00 | $724.62 | $169K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Mauricio Maxine Lum CAO, EVP & General Counsel | FTax | −1.71K | $724.62 | $1.24M | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Guzzi Anthony Chairman, President and CEO | FTax | −8.30K | $724.62 | $6.02M | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Nalbandian Jason R SVP, CFO, Chief Acct. Officer | FTax | −734.00 | $724.62 | $532K | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | Reid William P Director | AAward | +1.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | Lowe Carol P Director | AAward | +1.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | Altmeyer John W Director | AAward | +4.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | Nalbandian Jason R SVP, Chief Acct Officer & CFO | AAward | +4.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | Mauricio Maxine Lum CAO, EVP & General Counsel | AAward | +6.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | Guzzi Anthony Chairman, President and CEO | AAward | +25.00 | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also EME’s full analysis or the market-wide insider trading feed. The tabs above jump to EME’s other SEC data.
Source: SEC Form 4 filings for EME, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.